Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use

The costs of developing new pharmaceuticals have increased dramatically during the past decades. Contributing to these increased expenses are the increasingly extensive and more complex clinical trials required to generate sufficient evidence regarding the safety and efficacy of the drugs.  It is th...

Full description

Bibliographic Details
Main Author: Strömberg, Eric
Format: Doctoral Thesis
Language:English
Published: Uppsala universitet, Institutionen för farmaceutisk biovetenskap 2016
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-308452
http://nbn-resolving.de/urn:isbn:978-91-554-9766-8
id ndltd-UPSALLA1-oai-DiVA.org-uu-308452
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-3084522016-12-22T05:20:30ZApplied Adaptive Optimal Design and Novel Optimization Algorithms for Practical UseengStrömberg, EricUppsala universitet, Institutionen för farmaceutisk biovetenskapUppsala2016Nonlinear Mixed Effects ModelsPharmacometricsFisher Information MatrixApproximationOptimality CriterionParallelizationModel Based Adaptive Optimal DesignThe costs of developing new pharmaceuticals have increased dramatically during the past decades. Contributing to these increased expenses are the increasingly extensive and more complex clinical trials required to generate sufficient evidence regarding the safety and efficacy of the drugs.  It is therefore of great importance to improve the effectiveness of the clinical phases by increasing the information gained throughout the process so the correct decision may be made as early as possible.   Optimal Design (OD) methodology using the Fisher Information Matrix (FIM) based on Nonlinear Mixed Effect Models (NLMEM) has been proven to serve as a useful tool for making more informed decisions throughout the clinical investigation. The calculation of the FIM for NLMEM does however lack an analytic solution and is commonly approximated by linearization of the NLMEM. Furthermore, two structural assumptions of the FIM is available; a full FIM and a block-diagonal FIM which assumes that the fixed effects are independent of the random effects in the NLMEM. Once the FIM has been derived, it can be transformed into a scalar optimality criterion for comparing designs. The optimality criterion may be considered local, if the criterion is based on singe point values of the parameters or global (robust), where the criterion is formed for a prior distribution of the parameters.  Regardless of design criterion, FIM approximation or structural assumption, the design will be based on the prior information regarding the model and parameters, and is thus sensitive to misspecification in the design stage.  Model based adaptive optimal design (MBAOD) has however been shown to be less sensitive to misspecification in the design stage.   The aim of this thesis is to further the understanding and practicality when performing standard and MBAOD. This is to be achieved by: (i) investigating how two common FIM approximations and the structural assumptions may affect the optimized design, (ii) reducing runtimes complex design optimization by implementing a low level parallelization of the FIM calculation, (iii) further develop and demonstrate a framework for performing MBAOD, (vi) and investigate the potential advantages of using a global optimality criterion in the already robust MBAOD. Doctoral thesis, comprehensive summaryinfo:eu-repo/semantics/doctoralThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-308452urn:isbn:978-91-554-9766-8Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 1651-6192 ; 224application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Doctoral Thesis
sources NDLTD
topic Nonlinear Mixed Effects Models
Pharmacometrics
Fisher Information Matrix
Approximation
Optimality Criterion
Parallelization
Model Based Adaptive Optimal Design
spellingShingle Nonlinear Mixed Effects Models
Pharmacometrics
Fisher Information Matrix
Approximation
Optimality Criterion
Parallelization
Model Based Adaptive Optimal Design
Strömberg, Eric
Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
description The costs of developing new pharmaceuticals have increased dramatically during the past decades. Contributing to these increased expenses are the increasingly extensive and more complex clinical trials required to generate sufficient evidence regarding the safety and efficacy of the drugs.  It is therefore of great importance to improve the effectiveness of the clinical phases by increasing the information gained throughout the process so the correct decision may be made as early as possible.   Optimal Design (OD) methodology using the Fisher Information Matrix (FIM) based on Nonlinear Mixed Effect Models (NLMEM) has been proven to serve as a useful tool for making more informed decisions throughout the clinical investigation. The calculation of the FIM for NLMEM does however lack an analytic solution and is commonly approximated by linearization of the NLMEM. Furthermore, two structural assumptions of the FIM is available; a full FIM and a block-diagonal FIM which assumes that the fixed effects are independent of the random effects in the NLMEM. Once the FIM has been derived, it can be transformed into a scalar optimality criterion for comparing designs. The optimality criterion may be considered local, if the criterion is based on singe point values of the parameters or global (robust), where the criterion is formed for a prior distribution of the parameters.  Regardless of design criterion, FIM approximation or structural assumption, the design will be based on the prior information regarding the model and parameters, and is thus sensitive to misspecification in the design stage.  Model based adaptive optimal design (MBAOD) has however been shown to be less sensitive to misspecification in the design stage.   The aim of this thesis is to further the understanding and practicality when performing standard and MBAOD. This is to be achieved by: (i) investigating how two common FIM approximations and the structural assumptions may affect the optimized design, (ii) reducing runtimes complex design optimization by implementing a low level parallelization of the FIM calculation, (iii) further develop and demonstrate a framework for performing MBAOD, (vi) and investigate the potential advantages of using a global optimality criterion in the already robust MBAOD.
author Strömberg, Eric
author_facet Strömberg, Eric
author_sort Strömberg, Eric
title Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
title_short Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
title_full Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
title_fullStr Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
title_full_unstemmed Applied Adaptive Optimal Design and Novel Optimization Algorithms for Practical Use
title_sort applied adaptive optimal design and novel optimization algorithms for practical use
publisher Uppsala universitet, Institutionen för farmaceutisk biovetenskap
publishDate 2016
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-308452
http://nbn-resolving.de/urn:isbn:978-91-554-9766-8
work_keys_str_mv AT strombergeric appliedadaptiveoptimaldesignandnoveloptimizationalgorithmsforpracticaluse
_version_ 1718405564679061504